WO2000015665A3 - A method of producing a functional immunoglobulin superfamily protein - Google Patents
A method of producing a functional immunoglobulin superfamily protein Download PDFInfo
- Publication number
- WO2000015665A3 WO2000015665A3 PCT/DK1999/000484 DK9900484W WO0015665A3 WO 2000015665 A3 WO2000015665 A3 WO 2000015665A3 DK 9900484 W DK9900484 W DK 9900484W WO 0015665 A3 WO0015665 A3 WO 0015665A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- functional
- immunoglobulin superfamily
- class
- mhc class
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ511031A NZ511031A (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
CA002343313A CA2343313A1 (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
JP2000570203A JP2002524104A (en) | 1998-09-14 | 1999-09-14 | Methods for producing functionalized immunoglobulin superfamily proteins |
MXPA01002674A MXPA01002674A (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein. |
BR9914491-3A BR9914491A (en) | 1998-09-14 | 1999-09-14 | Process for producing a functional immunoglobulin superfamily protein |
KR1020017003306A KR20010075108A (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
EP99941420A EP1114063A2 (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
AU55047/99A AU771239C (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801155 | 1998-09-14 | ||
DKPA199801155 | 1998-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000015665A2 WO2000015665A2 (en) | 2000-03-23 |
WO2000015665A3 true WO2000015665A3 (en) | 2000-08-17 |
Family
ID=8101632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1999/000484 WO2000015665A2 (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1114063A2 (en) |
JP (1) | JP2002524104A (en) |
KR (1) | KR20010075108A (en) |
CN (1) | CN1326466A (en) |
AU (1) | AU771239C (en) |
BR (1) | BR9914491A (en) |
CA (1) | CA2343313A1 (en) |
MX (1) | MXPA01002674A (en) |
NZ (1) | NZ511031A (en) |
WO (1) | WO2000015665A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969042B2 (en) | 2004-08-19 | 2015-03-03 | Biogen Idec Ma Inc. | Refolding transforming growth factor beta family proteins |
US9138461B2 (en) | 2007-05-01 | 2015-09-22 | Biogen Ma Inc. | Compositions and methods for increasing vascularization |
US9404916B2 (en) | 2008-09-20 | 2016-08-02 | University College Cardiff Consultants Limited | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002240818C1 (en) | 2001-03-14 | 2008-11-06 | Agilent Technologies, Inc. | MHC molecule constructs and their uses for diagnosis and therapy |
WO2003097669A2 (en) * | 2002-05-17 | 2003-11-27 | Københavns Universitet | Method for purifying denatured proteins having a desired disulfide bond configuration |
US20040072262A1 (en) * | 2002-10-11 | 2004-04-15 | Montero-Julian Felix A. | Methods and systems for detecting MHC class I binding peptides |
WO2004072112A2 (en) * | 2003-02-11 | 2004-08-26 | Københavns Universitet | A method for formulating mhc-like molecules for long time storage |
EP1706720A4 (en) * | 2003-10-31 | 2007-02-28 | Vitatex Inc | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
WO2006009838A2 (en) | 2004-06-17 | 2006-01-26 | Beckman Coulter, Inc. | Mycobacterium tuberculosis epitopes and methods of use thereof |
TWI501774B (en) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | Treatments for neurological disorders |
CL2007002225A1 (en) * | 2006-08-03 | 2008-04-18 | Astrazeneca Ab | SPECIFIC UNION AGENT FOR A RECEIVER OF THE GROWTH FACTOR DERIVED FROM PLATES (PDGFR-ALFA); NUCLEIC ACID MOLECULA THAT CODIFIES IT; VECTOR AND CELL GUESTS THAT UNDERSTAND IT; CONJUGADO UNDERSTANDING THE AGENT; AND USE OF THE AGENT OF A |
EP2361930A3 (en) | 2007-03-26 | 2011-10-26 | Dako Denmark A/S | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
WO2009003493A2 (en) | 2007-07-03 | 2009-01-08 | Dako Denmark A/S | Mhc multimers, methods for their generation, labeling and use |
EP2188302B1 (en) | 2007-07-09 | 2017-11-01 | Genentech, Inc. | Prevention of disulfide bond reduction during recombinant production of polypeptides |
WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
GB2453589A (en) | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
US10968269B1 (en) | 2008-02-28 | 2021-04-06 | Agilent Technologies, Inc. | MHC multimers in borrelia diagnostics and disease |
WO2010009735A2 (en) | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Combinatorial analysis and repair |
US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
CN103364558A (en) * | 2013-07-17 | 2013-10-23 | 江阴泽成生物技术有限公司 | Human tumor marker carcinoembryonic antigen (CEA) magnetic particle chemiluminiscence immunoassay kit and detection method |
CN109402036A (en) * | 2018-11-07 | 2019-03-01 | 河北科技师范学院 | The application of ox source Salmonella enteritidis trxB gene delection |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993022332A2 (en) * | 1992-04-24 | 1993-11-11 | Board Of Regents, The University Of Texas System | Recombinant production of immunoglobulin-like domains in prokaryotic cells |
WO1994006813A1 (en) * | 1992-09-15 | 1994-03-31 | The Rockefeller University | Major histocompatibility complex molecules and modifications thereof |
WO1995011702A1 (en) * | 1993-10-25 | 1995-05-04 | Anergen, Inc. | Prokaryotic expression of mhc proteins |
US5529921A (en) * | 1992-02-19 | 1996-06-25 | Scripps Research Institute | In vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and β2-microglobulin |
WO1997044667A2 (en) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells |
-
1999
- 1999-09-14 CA CA002343313A patent/CA2343313A1/en not_active Abandoned
- 1999-09-14 BR BR9914491-3A patent/BR9914491A/en not_active IP Right Cessation
- 1999-09-14 AU AU55047/99A patent/AU771239C/en not_active Ceased
- 1999-09-14 MX MXPA01002674A patent/MXPA01002674A/en unknown
- 1999-09-14 NZ NZ511031A patent/NZ511031A/en unknown
- 1999-09-14 WO PCT/DK1999/000484 patent/WO2000015665A2/en not_active Application Discontinuation
- 1999-09-14 KR KR1020017003306A patent/KR20010075108A/en not_active Application Discontinuation
- 1999-09-14 EP EP99941420A patent/EP1114063A2/en not_active Withdrawn
- 1999-09-14 JP JP2000570203A patent/JP2002524104A/en active Pending
- 1999-09-14 CN CN99813211A patent/CN1326466A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5529921A (en) * | 1992-02-19 | 1996-06-25 | Scripps Research Institute | In vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and β2-microglobulin |
WO1993022332A2 (en) * | 1992-04-24 | 1993-11-11 | Board Of Regents, The University Of Texas System | Recombinant production of immunoglobulin-like domains in prokaryotic cells |
WO1994006813A1 (en) * | 1992-09-15 | 1994-03-31 | The Rockefeller University | Major histocompatibility complex molecules and modifications thereof |
WO1995011702A1 (en) * | 1993-10-25 | 1995-05-04 | Anergen, Inc. | Prokaryotic expression of mhc proteins |
WO1997044667A2 (en) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells |
Non-Patent Citations (6)
Title |
---|
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; MOLLOY P E ET AL: "Production of soluble single-chain T-cell receptor fragments in Escherichia coli trxB mutants.", XP002131051, retrieved from STN Database accession no. 1998346783 * |
GARBOCZI D N ET AL: "HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1992 APR 15) 89 (8) 3429-33., XP002131059 * |
MOLECULAR IMMUNOLOGY, (1998 FEB) 35 (2) 73-81. * |
PARKER K C ET AL: "An HLA-A2/beta 2-microglobulin/peptide complex assembled from subunits expressed separately in Escherichia coli.", MOLECULAR IMMUNOLOGY, (1992 MAR) 29 (3) 371-8., XP000876800 * |
PLAKSIN D ET AL: "A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution?.", JOURNAL OF EXPERIMENTAL MEDICINE, (1996 OCT 1) 184 (4) 1251-8., XP000876791 * |
STEVENS JAMES ET AL: "Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries.", JOURNAL OF BIOLOGICAL CHEMISTRY JAN. 30, 1998, vol. 273, no. 5, 30 January 1998 (1998-01-30), pages 2874 - 2884, XP002136475, ISSN: 0021-9258 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969042B2 (en) | 2004-08-19 | 2015-03-03 | Biogen Idec Ma Inc. | Refolding transforming growth factor beta family proteins |
US9138461B2 (en) | 2007-05-01 | 2015-09-22 | Biogen Ma Inc. | Compositions and methods for increasing vascularization |
US9404916B2 (en) | 2008-09-20 | 2016-08-02 | University College Cardiff Consultants Limited | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
Also Published As
Publication number | Publication date |
---|---|
WO2000015665A2 (en) | 2000-03-23 |
NZ511031A (en) | 2003-11-28 |
EP1114063A2 (en) | 2001-07-11 |
AU5504799A (en) | 2000-04-03 |
BR9914491A (en) | 2002-01-15 |
CN1326466A (en) | 2001-12-12 |
CA2343313A1 (en) | 2000-03-23 |
JP2002524104A (en) | 2002-08-06 |
AU771239B2 (en) | 2004-03-18 |
AU771239C (en) | 2004-10-14 |
MXPA01002674A (en) | 2002-06-04 |
KR20010075108A (en) | 2001-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000015665A3 (en) | A method of producing a functional immunoglobulin superfamily protein | |
EP1108724A3 (en) | Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules | |
AU9125198A (en) | Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins | |
WO2002072605A3 (en) | Expression technology for proteins containing a hybrid isotype antibody moiety | |
PL374311A1 (en) | Methods for purifying protein | |
WO1996018731A3 (en) | Isolation of nucleic acid | |
WO1996022308A3 (en) | Appetite suppression factor and related methods | |
EP2330197A3 (en) | Antagonistic selective binding agents of osteoprotegerin binding protein | |
WO2003020932A1 (en) | Novel secretory proteins and dna thereof | |
WO2002042424A3 (en) | Seed-preferred regulatory elements and uses thereof | |
AU2002348563A1 (en) | Nucleic acid enrichment | |
WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
CA2079454A1 (en) | Steroid 5.alpha.-reductases | |
DE69604240T2 (en) | Polyarylene sulfide, process for its preparation and this comprehensive mass | |
EP1304383A3 (en) | Sugarcane bacilliform virus promoter | |
WO1997043409A3 (en) | Method of providing novel dna sequences | |
WO1995029236A3 (en) | Lymphocyte activation antigens and antibodies thereto | |
WO1996027665A3 (en) | Neuron-restrictive silencer factor proteins | |
AU2883897A (en) | Spruce budworm antifreeze proteins, genes and methods of using same | |
WO2000028014A3 (en) | Plastid transformation of solanaceous plants | |
EP0270930A3 (en) | Substantially pure enzyme-antibody conjugate preparations | |
MX9806041A (en) | PURIFIED SR-p70 PROTEIN. | |
AU3107699A (en) | Novel forms of t cell costimulatory proteins, nucleic acid molecules, and uses thereof | |
WO1998032858A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
DE69533626D1 (en) | TIOREDIOXINE H FROM TWENTY AND HARD WHEAT AND SIMILAR PROTEINS, THESE ENCODING DNA FRAGMENTS AND METHOD FOR THE PRODUCTION THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99813211.X Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2343313 Country of ref document: CA Ref document number: 2343313 Country of ref document: CA Kind code of ref document: A Ref document number: 2000 570203 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017003306 Country of ref document: KR Ref document number: PA/a/2001/002674 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 55047/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 511031 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999941420 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09787032 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999941420 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017003306 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 55047/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999941420 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017003306 Country of ref document: KR |